Metabolomics: The Tool to Help Realize Omics’ Full Potential
What is Metabolomics All About?
Metabolomics is the identification of small molecules known as metabolites. It’s a powerful companion to other commonly used omics techniques: genomics, transcriptomics, and proteomics. While these techniques provide information about genetic and functional potential, metabolomics goes a layer deeper by providing phenotypic information.
Our genomes, transcriptomes, proteomes, and metabolomes don’t exist in a vacuum—they impact and are impacted by one another as well as by the outside environment. Metabolomics is the study of specific phenotypes that result from these intricate and complex interactions.
When combined with these omics, metabolomics provides a complete puzzle explaining the intricate mechanisms behind living organisms. Only metabolomics can reveal the result of these complex interactions.
How is Metabolomics Applied?
Metabolomics is used across the academic, clinical, and industrial sectors, from identifying disease biomarkers to accelerating pharmaceutical drug discovery to aiding farmers in selecting the most promising cultivars.
Want to know more? Complete the form to get in touch with our experts.
Who We Are
Metabolon deciphers thousands of discrete chemical signals from genetic and non-genetic factors to reveal biological pathways. We make connections where other ‘omics cannot, and provide the definitive representation of the phenotype.
- Our platform offers the most sensitive and complete data analysis methods for detecting biochemical change to deliver the most complete view of the phenotype.
- Our proprietary library contains over 5,400 metabolites.
- We set the standard for functional metabolite identification by offering four core capabilities: Coverage, Competency, Comparability, and Capacity.
- Our expert view on metabolomics has been published in 2,000+ publications.
- We provide quality control at every stage. Our rigorous data governance program and adherence to important U.S. federal and International standards and regulations to provide the precision and reproducibility necessary for your study success. We are ISO 9001:2015 certified.
- With approximately 10,000 completed projects behind us, our institutional knowledge is unmatched.
Want to know more? Complete the form to get in touch with our experts.
Accelerating Life Science Research
Our proprietary platforms and informatics are delivering biomarker discoveries, innovative diagnostic tests, and valuable data for genomics and population health initiatives. Metabolon’s expertise is also accelerating research and product development across the pharmaceutical, biotechnology, consumer products, agriculture, and nutrition industries, as well as academic and government organizations.
Biomarker Development Strategy
Metabolon guides clients to ensure study integrity and high-quality data generation through all phases of the biomarker development process in compliance with regulatory standards.
According to the context of use of your biomarkers, we can provide Fit-For-Purpose Validation of our targeted panels, and we have capability to adhere to Good Clinical Practice (GCP) / Good Clinical Laboratory Practice (GCLP) standards with extensive Method Validation according to FDA Bioanalytical Method Validation Guidance, 2018 or EMA Guideline on Bioanalytical Method Validation, 2011.
A Continuum of Metabolomics Capabilities
Metabolon offers metabolomics services across the research continuum, from discovery to biomarker quantification and diagnostic test development. Our team of experts works with you to develop a tailored study design to meet your research need across all areas of life sciences.
Metabolon has pioneered industry-leading standards in metabolomic analyses. We have built upon this technology and expertise to also offer the Complex Lipid Panelas well as pre-developed and custom-targeted panels and assays for research and clinical trials.
Improving the Probability of Success from Start to Finish
Many laboratories have metabolite profiling or analytical chemistry capabilities, but none have the extensive library of metabolite standards or informatics systems that power Metabolon’s platform. Metabolon has been granted over 200 patents covering its technology, methods, and a growing portfolio of biomarkers. Our unmatched expertise and proprietary metabolomics systems ensure that our clients receive the most accurate, comprehensive picture of the metabolome.
Want to know more? Complete the form to get in touch with our experts.
- N25 years of experience with over 15,000 projects completed
- N45+ PhDs on staff
- N5,400+ metabolites in our library
- NWe continuosly partner with global cohorts and medical centers of excellence to reveal promising new biomarkers
- NPublished in over 4,000+ publications
